Few Older European Men Aware of Prostate Function
New survey reveals low levels of awareness about prostate health in men older than 50 years of age
Benign Prostatic Hyperplasia
NLR May Predict Intravesical Prostatic Protrusion in BPH
Neutrophil-to-lymphocyte ratio (NLR) may be useful as a surrogate marker of intravesical prostatic protrusion (IPP) in men with benign prostatic hyperplasia, according to a new report. IPP is an anatomical feature caused by the growth of prostatic lateral and median lobes. The new finding is from a study of 250 men older than 50 years…
Statin Use May Lessen Prostate Growth
Study of participants in the REDUCE trial found that statin use among dutasteride recipients was associated with a small but significant decrease in estimated mean prostate volume compared with nonuse over a 4-year period.
Prostatic Calcifications May Increase Storage LUTS, Nocturia Risk
Prostate calcifications in men with benign prostatic hyperplasia are associated with nearly 3-fold increased odds of storage lower urinary tract symptoms and nocturia, a study found.
Real-World Study Confirms Prostatic Urethral Lift Benefits in BPH
Post-marketing data show that prostatic urethral lift provides symptom relief in patients outside of the controlled clinical trial setting.
Marijuana Tied to Increased Risk for LUTS Medications in BPH
Marijuana use also linked to worse overall semen parameters due to induction of oxidative stress
BPH Meds Found to Delay Prostate Cancer Diagnosis
Men treated with 5-alpha reductase inhibitors were diagnosed with prostate cancer 2 years later than men not using these drugs.
Water Vapor Therapy for BPH Shows Good Short-Term Efficacy
By 3 and 6 months, flow rate, post void residual, IPSS, quality of life, and prostate volume improved in patients treated with the Rezum system, which uses convective heating to ablate prostate tissue.
Aquablation Effective for BPH Despite Large Prostates
Men with larger vs smaller prostate gland sizes treated with Aquablation experienced similar improvement in International Prostate Symptom Score.
Risk for T2DM Increased With Use of 5α-Reductase Inhibitors
Increased risk seen among men using dutasteride, finasteride for benign prostatic hyperplasia
